UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
diabetes (8) 8
female (8) 8
humans (8) 8
middle aged (8) 8
life sciences & biomedicine (7) 7
male (7) 7
science & technology (7) 7
aged (6) 6
diabetes mellitus, type 2 - drug therapy (5) 5
double-blind method (5) 5
risk factors (5) 5
type 2 diabetes (5) 5
abridged index medicus (4) 4
cardiovascular diseases (4) 4
care and treatment (4) 4
clinical trials (4) 4
diabetes mellitus (4) 4
general & internal medicine (4) 4
hypoglycemic agents - therapeutic use (4) 4
medicine, general & internal (4) 4
uracil - analogs & derivatives (4) 4
acute coronary syndrome (3) 3
cardiovascular disease (3) 3
cardiovascular diseases - mortality (3) 3
diabetes mellitus, type 2 - complications (3) 3
heart attacks (3) 3
heart failure (3) 3
hypoglycemic agents - adverse effects (3) 3
internal medicine (3) 3
myocardial infarction (3) 3
piperidines - therapeutic use (3) 3
treatment outcome (3) 3
uracil - therapeutic use (3) 3
acute coronary syndromes (2) 2
adult (2) 2
analysis (2) 2
angiotensin (2) 2
canagliflozin (2) 2
cardiovascular system & cardiology (2) 2
cerebral infarction (2) 2
clinical outcomes (2) 2
complications and side effects (2) 2
coronary heart disease (2) 2
creatinine (2) 2
creatinine - blood (2) 2
diabetes mellitus, type 2 (2) 2
dipeptidyl-peptidase iv inhibitors - therapeutic use (2) 2
drug dosages (2) 2
drug therapy (2) 2
end-stage renal disease (2) 2
endocrinology & metabolism (2) 2
endocrinology, diabetes and metabolism (2) 2
enzymes (2) 2
glomerular filtration rate (2) 2
heart diseases (2) 2
hemoglobin (2) 2
hospitalization (2) 2
kidney diseases (2) 2
kidney transplantation (2) 2
kidneys (2) 2
meeting abstract (2) 2
mortality (2) 2
patient outcomes (2) 2
peripheral vascular disease (2) 2
piperidines - adverse effects (2) 2
proportional hazards models (2) 2
renal failure (2) 2
renin (2) 2
research (2) 2
risk (2) 2
sodium (2) 2
stroke (2) 2
uracil - adverse effects (2) 2
10155 (1) 1
11 medical and health sciences (1) 1
[sdv.mhep.csc]life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (1) 1
acute coronary syndrome - mortality (1) 1
acute coronary syndrome - physiopathology (1) 1
acute coronary syndrome - prevention & control (1) 1
administration, oral (1) 1
adrenocorticotropic hormone - analysis (1) 1
aged, 80 and over (1) 1
alogliptin (1) 1
amputation (1) 1
anemia (1) 1
angina (1) 1
angina pectoris (1) 1
angina, unstable (1) 1
angina, unstable - complications (1) 1
angina, unstable - drug therapy (1) 1
angina, unstable - etiology (1) 1
angiotensin ii (1) 1
angiotensin-converting enzyme inhibitors - therapeutic use (1) 1
angiotensin-converting enzyme inhibitors dipeptidyl dipeptidase 4 inhibitors (1) 1
atrasentan - administration & dosage (1) 1
atrasentan - therapeutic use (1) 1
atrasentan/administration & dosage (1) 1
biological and medical sciences (1) 1
biomarkers (1) 1
blood glucose (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 24, pp. 2295 - 2306
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Coronary heart disease | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Hou, Fan-Fan and Makino, Hirofumi and Melnick, Joel Z and Miller, Michael G and Perkovic, Vlado and Tobe, Sheldon and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Vogel, Daniel and Santos, Juan and Fraenkel, Margaret and Davis, Tim and Cooke, Duncan and Roger, Simon and Toussaint, Nigel and Chan, Doris and Endre, Zoltan and Prager, Rudolf and Mayer, Gert and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Prompt, Carlos Alberto and Zanella, Maria and D'Avila, Domingos and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Gutierrez, Vicente and Godoy, Gonzalo and Liu, Zhangsuo and Zhao, Minghui and Su, Benli and Xu, Yan and Yang, Jinkui and Shi, Bingyin and Shi, Wei and Hao, Chuanming and Xing, Changying and Hou, Fanfan and Li, Yuxiu and Chen, Nan and Jia, Weiping and Yu, Shengqiang and Weng, Jian and Xu, Gang and Ding, Xiaoqiang and Rychlik, Ivan and Oplustilova, Alexandra and Bartaskova, Dagmar and Honova, Vaclava and Chmelickova, Hana and Petr, Martin and Bucek, Petr and Zahumensky, Emil and Povlsen, Johan and Egstrup, Kenneth and Oczachowska-Kulik, Anna and Rossing, Peter and Lahtela, Jorma and Kantola, Ilkka and Petit, Catherine and Combe, Christian and Zaoui, Philippe and Esnault, Vincent and Urena Torres, Pablo and Dussol, Bertrand and Bieler, Tasso and ... and SONAR Committees and Investigators and SONAR Comm Investigators
The Lancet (British edition), ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
yes | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Evidence-based medicine | Randomization | Renin | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
International journal of women's health and reproduction sciences, 04/2018, Volume 6, Issue 2, pp. 140 - 143
Journal Article
Journal Article